SeekingAlpha · Jul 30, 2026
Ingevity Corporation (NGVT) Q2 2026 Earnings Call Transcript
Ingevity Corporation (NGVT) Q2 2026 Earnings Call July 30, 2026 10:00 AM EDTCompany ParticipantsMichael Walsh - Vice President of Investor RelationsDavid Li...
NG
NYSE · NGVT
Ingevity Corporation
Basic Materials · Chemicals - Specialty
$75.33
Down-$0.86 (-1.13%)
Updated Aug 14, 2026, 2:09 AM
SID Score
6.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.19B
- P/E ratio
- -10.14
- Dividend yield
- 0.00%
- 52-week range
- $45.85 – $79.29
- Volume
- 223.02K
- Avg. volume
- 259.47K
Price performance
NGVT price history
1M range · 0 trading sessions · Daily adjusted prices
NGVT does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest NGVT news
The latest Smart Investors Daily articles mentioning NGVT.
Stock researchCompany · Overview
NGVT research
Overview
Company profile and research snapshot.
Company profile
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $70.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Feb 27, 2026 | Wells Fargo | Equal-Weight | — |
| Jan 29, 2026 | Wells Fargo | Equal-Weight | — |
| Dec 19, 2025 | Wells Fargo | Equal-Weight | — |
| Dec 10, 2025 | BMO Capital | Outperform | — |
| Nov 12, 2025 | Wells Fargo | Equal-Weight | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Jul 30, 2026
Ingevity Corporation 2026 Q2 - Results - Earnings Call Presentation
2026-07-30. The following slide deck was published by Ingevity Corporation in conjunction with their 2026 Q2 earnings call.
ChartMill · Jul 29, 2026
Ingevity (NYSE:NGVT) Q2 Results: Earnings Beat, Revenue Slightly Light
Ingevity Q2 earnings beat estimates at $1.74 EPS, but revenue slightly missed at $314.1M. Company raised full-year 2026 guidance, citing strong operational execution across segments.
Benzinga · Jul 29, 2026
Ingevity Raises FY2026 Adj EPS Guidance from $4.70-$5.20 to $5.00-$5.45 vs $5.01 Est; Affirms FY2026 Sales Guidance of $1.050B-$1.150B vs $1.109B Est
Ingevity (NYSE:NGVT) raises FY2026 Adj EPS guidance from $4.70-$5.20 to $5.00-$5.45 vs $5.01 analyst estimate. Affirms FY2026 sales outlook from $1.050 billion-$1.150 billion to $1.050 billion-$1.150 billion vs $1.109
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
